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SUMMARY
Introduction Glaucoma is a chronic, progressive disease of the optic nerve which if left untreated can 
lead to blindness at end stages. A decrease of intraocular pressure (IOP) has proven to slow down the 
progression of the disease. IOP decrease can be achieved by medical, laser and surgical treatment.
Objective The aim of this study was to evaluate the response of patients with medically uncontrolled 
primary open angle glaucoma to selective laser trabeculoplasty (SLT).
Methods The study involved baseline characteristics recorded for each of 35 patients (48 eyes) in whom, 
despite being under full medication we could not achieve a satisfactory IOP. Patients, who had pressure 
above 25 mmHg under the maximal medication therapy, were not included into the study and were 
referred for surgical treatment. IOP was measured on admission, 1 hour, 7 days, 1, 3, 6 and 12 months after 
SLT. We considered satisfactory surgical result if IOP was decreased more than 20% of the initial value. 
Also, we investigated the influence of baseline IOP on SLT outcome after 12 months. Patient inclusion 
criteria were inability to reach target IOP with maximal medical therapy. Exclusion criteria were congenital 
glaucoma, any type of angle closure glaucoma, advanced-stage glaucoma, eyes with previous laser or 
surgical glaucoma applications and patients with baseline IOP >25 while fully medicated. Patients who 
could not be followed for at least 12 months were also excluded.
Results The mean age of our patients was 73±12 years. The mean baseline IOP was 20.48 mmHg 
(SD=1.91), and the mean change in IOP from baseline of the treated eye after one year was 4.47 mmHg 
(SD=2.12). In eyes with a higher baseline IOP the reduction of pressure at the end of the study was 
significantly higher. Satisfactory effect of IOP reduction after one year was achieved in 64.58% of eyes. 
The IOP reduction did not show to be dependent as regarding age and gender.
Conclusion SLT effectively lowers IOP in patients with primary open-angle glaucoma, and the intervention 
is not followed by significant complications. Our results confirm that the IOP reduction is more significant 
if the initial value is higher. Our first reliable results of IOP reduction were confirmed one month after 
the procedure so that the procedure should not be repeated before one month has elapsed. The study 
is limited by a small number of eyes, which is insufficient to make a complete case analysis.
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INTRODUCTION
Glaucoma is a chronic, progressive disease 
of the optic nerve which if left untreated can 
lead to visual field decay and blindness at end 
stages [1]. Decrease of the intraocular pressure 
(IOP) has proven to slow the progression of the 
disease [2]. IOP decrease can be achieved by 
medical, surgical and laser treatment. Selective 
laser trabeculoplasty (SLT) was introduced by 
Latina and Park [3] in 1995 as an option for the 
treatment of open-angle glaucoma (OAG) and 
has been in commercial use since 2001. This 
procedure calls for Q-switched, frequency dou-
bled laser with a wavelength of 532 nm to be 
directed at the trabecular meshwork (TM) with 
the pulse duration of 3 ns. Using a short dura-
tion and wavelength of 532 nm spares the TM 
from coagulation necrosis and affects mainly 
pigmented cells. Effective IOP reduction and 
minimal side effects have been proven during 
clinical trials of SLT [4].
The position of SLT on the treatment scale is 
still a cause of great controversy. This treatment 
consists of the application of laser spots in the 
TM, the structure responsible for the aqueous 
humor drainage, leading to an increase in the 
outflow facility through it and in consequence, 
decreasing IOP [5]. Advantages of such treat-
ment are in the fact that it does not depend on 
chronic instillation of eye drops nor does it have 
as many complications as incisional surgery.
OBJECTIvE
The aim of this study was to analyze the effects 
of laser trabeculoplasty on Serbian patients 
with medically uncontrolled OAG, particular-
ly the significance of IOP reduction compared 
to baseline IOP, correlation between baseline 
IOP value and percentage of IOP reduction 12 
months after SLT procedure and influence of 
sex and age on the value of IOP reduction.     
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METHODS
All patients included in this study gave informed consent 
and the study was approved by the institutional review 
board and ethics committee. Baseline characteristics of all 
patients were recorded, including age, gender, diagnosis, 
baseline IOP, and the number and the type of taken medi-
cations, as well as the degree of angle pigmentation which 
was evaluated at the time of the procedure. Thirty-five 
patients (48 eyes) were enrolled in this prospective study 
conducted from June 2011 to June 2012.
All studied patients had primary open-angle glaucoma 
(POAG) which was uncontrolled despite maximum medi-
cation therapy. All eyes were treated by SLT. Starting back 
at 4 weeks before SLT procedure IOP was measured at least 
2 times in all patients so as to ascertain the baseline IOP as 
a mean value of these measurements. IOP was measured 
using the Goldmann applanation tonometer. On the day 
of SLT, IOP was measured and one drop of 0.5% apraclo-
nidine was instilled in the studied eye one hour before 
treatment in order to prevent IOP spikes [6, 7]. As preop-
erative assessment we performed ophthalmic examination, 
Snellen visual acuity test, IOP measurement by Goldmann 
applanation tonometry, slit-lamp examination and goni-
oscopy, and funduscopy with evaluation of cup:disc ratio 
and pallor. Visual field testing was performed first in all 
patients as the initial diagnostic step.
Patient inclusion criteria were inability to reach tar-
get IOP with maximal medical therapy in patients with 
POAG who were older than 18 years. Exclusion crite-
ria were congenital glaucoma, any type of angle closure 
glaucoma, advanced-stage glaucoma, eyes with previous 
laser or surgical glaucoma applications, eyes with previ-
ous anterior segment surgery within the past 6 months 
and patients with baseline IOP >25 while fully medicated. 
Patients who could not be followed for at least 12 months 
were also excluded.
The procedure was performed with the patient under 
topical anesthesia using benoxinate hydrochloride 0.4%. 
With the patient seated at the laser slit-lamp system, the 
Goldmann three-mirror goniolens or Latina lens was 
placed on the eye with methylcellulose 2%. The patients 
were treated with the Ellex, Tango® SLT laser (Ellex Medi-
cal Pty. Ltd, Adelaide, Australia) a frequency-doubled, 
Q-switched Nd:YAG laser emitting at 532 nm with pulse 
duration of 3 ns and a spot size of 400 μm. A low-power 
helium–neon laser served as an aiming beam to provide 
easy targeting of the treatment area. The laser is capable 
of delivering pulse energies ranging from 0.3 to 2.6 mJ. 
Treatment began at 0.8 mJ and was titrated according to 
the response. If cavitation bubbles appeared the laser en-
ergy was reduced by 0.1 mJ until no bubbles formed, and 
treatment was continued at this energy level. If no cavita-
tion bubble was observed, the pulse energy was increased 
by 0.1 mJ until bubble formation and then decreased as 
described above. Sometimes higher energy was required 
for the treatment of the superior, less pigmented angle. Ap-
proximately 100 adjacent but nonoverlapping laser spots 
were placed over 360° of the TM.
Immediately after the laser treatment, diclofenac eye 
drops were administered once in the treated eye then three 
times daily for 3 days. The IOP of the treated eye was meas-
ured and recorded 1 hour after surgery. The same preop-
erative antiglaucoma medication regimen was continued. 
The patients were evaluated at 1 hour, 1 week, and at 1, 3, 6 
and 12 months. At each visit, the visual acuity and IOP were 
measured, and the slit-lamp examination of the anterior seg-
ment was performed. All major and minor complications 
and complaints were recorded and treated appropriately.
The data was analyzed using SPSS statistical software 
(version 17) using ANOVA for repeated measures, T test 
for dependent samples and Tukey’s multiple comparison 
test. A p value of less than 0.05 was considered to be sta-
tistically significant.
RESULTS
This paper presents the results of a prospective, nonran-
domized, interventional cohort study undertaken at our 
institution to assess the response to SLT according to base-
line medical treatment, age, gender and baseline intraocu-
lar pressure. The total of 35 patients (48 eyes) was included 
in the study. Baseline characteristics of included patients 
are presented in Table 1. The patients’ average age was 
73.27 (SD=6.13) and baseline IOP was 20.48 (SD=1.91).
On the first check-up 1 hour after SLT treatment IOP 
value dropped to 17.18 (SD=2.95), and after one week IOP 
dropped to 16.25 (SD=2.04). At one month checkup IOP 
dropped to 15.93 (SD=1.93). Reduction in IOP was main-
tained at a yearly checkup when average IOP value was 
16.00 (SD=1.45). IOP was also checked at 3 and 6 months 
milestones and results are presented in Table 2. Results 
Table 1. Baseline characteristics of patients
Characteristics Male (%) Female (%) All
Number (%)
Patients 16 (45.71) 19 (54.29) 35
Eyes 21 (43.75) 27 (56.25) 48
Age (years)
Mean 74 72.7 73.27
SD 6.52 5.88 6.14
Min 61 63 61
Max 84 85 85
Baseline IOP 
(mmHg)
Mean 20.61 20.37 20.48
SD 1.90 1.94 1.91
Min 18 17 17
Max 25 25 25
IOP – intraocular pressure; SD – standard deviation; Min – minimal value;  
Max – maximal value
Table 2. Intraocular pressure (IOP) values over time (mmHg)
IOP values (mmHg)
Period Mean SD Min Max
Base 20.48 1.91 17 25
1 hour 17.18 2.96 11 26
7 days 16.96 2.04 11 23
1 month 15.94 1.92 10 21
3 months 15.73 1.79 12 19
6 months 16.04 1.84 11 21
12 months 16.00 1.45 12 20  
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presented in Table 3 show that the main IOP reduction 
happens up to one month after SLT treatment. Follow-up 
measurements at 3, 6 and 12 months checkups show small 
difference compared to values at one month checkup.
We used paired-samples T test to compare the means 
of baseline IOP and IOP after 12 months and difference is 
highly statistically significant (p<0.001).
Percentage of IOP reduction after 12 months related to 
the starting value show that in 33% of patients the reduc-
tion was between 10 and 20% of starting value, in 31% re-
duction was 20-30%, 22.9% reduction was greater than 30% 
while in 12.5% of patients the effect was insufficient mean-
ing that the reduction was between 0 and 10% (Table 4).
We divided our patients into three groups based on the 
baseline IOP. In the first group we selected patients with 
the baseline IOP of 17-19 mmHg. The second group con-
sisted of patients with the baseline IOP of 20-22 mmHg, 
and in the third group of patients with the IOP of 23-25 
mmHg. Then we analyzed the influence of baseline IOP at 
outcome of SLT treatment. We found that the higher the 
baseline IOP the greater was the rate of reduction. Results 
showed the average IOP reduction of 21.39% from the 
baseline value (SD=8.64) with the highest percentage of 
reduction detected in the group of patients with the base-
line IOP of 23-25 mmHg, with the reduction measured 
at 31.19% (SD=2.72), while in the group of patients with 
baseline IOP of 20-22 mmHg, measured at 22.4%, and in 
the group with baseline IOP of 17-19 mmHg the reduction 
was lowest and it was measured at 15.54% (Table 5). We 
used the Tukey’s multiple comparison test to compare the 
difference between each pair of means with appropriate 
adjustment for the multiple testing and we found statisti-
cally significant differences of the IOP reduction in group 
1 as compared with group 2 and group 3 (Table 6). When 
analyzing our data set we could not find any correlation 
between the age and effect of SLT. Also, no significant dif-
ference was found of the effect of SLT on IOP between 
male and female patients.
All patients enrolled in the study were on fully toler-
ated local medical therapy. The mean number of different 
eye drops was 2.83. None of the patients were on systemic 
glaucoma therapy with carbonic anhydrase inhibitor 
(CAI). After one year of follow-up the mean number of 
eye drops was reduced to 2.68.
In regard to the safety issues, we noticed a mild ante-
rior chamber inflammation in 7 eyes (14.58%). At 7 days 
follow-up there were no signs of inflammation in any of 
the eyes. After surgery all patients were treated with di-
clofenac eye drops. In addition, 2 patients reported a mild 
ocular discomfort during treatment which vanished after 
lowering the SLT power. No patients complained of pain 
after treatment. IOP spikes greater than 5 mmHg were 
noticed in 3 eyes (6.25%), and were reduced after 7 days.
DISCUSSION
Selective laser trabeculoplasty proved to be a useful tool 
for the treatment of OAG and ocular hypertension [8]. It is 
still unclear, which is the precise mechanism of action that 
causes the decrease in IOP following laser trabeculoplasty. 
The cellular theory proposes that there is a migration of 
macrophages at the site of laser treatment and their phago-
cytic activity clears the debris from TM and improves 
outflow [9]. According to the mechanical theory thermal 
damage of TM, which results in collagen shrinkage and 
scarring from the laser, allows better drainage of aqueous 
humor [10]. The third possible mechanism of action for 
SLT-induced IOP lowering is that there is a release of extra 
amounts of enzyme known as matrix metalloproteinases 
(MMPs) to clean TM and improve aqueous humor flow 
through TM [11, 12, 13].
In our group of patients, a satisfactory reduction of IOP 
(>20%) by usage of SLT was found to be 64.58% which is a 
similar percentage reported by other authors [14, 15, 16]. 
Achieved IOP reduction by 10-20% of baseline value was 
found to be 25%, which can be assessed as useful, taking 
into account that all patients were fully medicated before 
the procedure. Our study showed that SLT had the same 
effect on IOP both in male and female patients, which is 
consistent with findings of other authors as well as that the 
age also did not show significant influence on SLT effects.
If analyzing the average IOP values measured over the 
periods of 1 hour, 7 days, 1 month, 3 months, 6 months 
and one year after SLT intervention and compare it to the 
baseline IOP value, (Table 3) we can see that the IOP value 
reduction stabilizes after 1 month period following the 
Table 3. Intraocular pressure (IOP) reduction over time
Period
IOP reduction
mmHg %
1 h 3.29 16.07
7 days 3.52 17.19
1 month 4.54 22.17
3 months 4.75 23.19
6 months 4.44 21.67
12 months 4.47 21.87
Table 4. Reduction percentage by groups
Group – reduction 0–10% 10–20% 20–30% >30%
Number of eyes 5 12 21 10
% 10.42 25.00 43.75 20.83
Table 5. Influence of baseline IOP on outcome of selective laser 
trabeculoplasty
Baseline IOP groups Mean reduction (%) N SD
Group 1 (17–19 mmHg) 15.54 15 6.35
Group 2 (20–22 mmHg) 22.46 27 8.30
Group 3 (23–25 mmHg) 31.19 6 2.72
All groups 21.39 48 8.64
Table 6. Tukey’s multiple comparison test to compare the difference 
between each pair of means
Baseline IOP groups Group 1
(M=15.54)
Group 2
(M=22.46)
Group 3
(M=31.19)
Group 1 (17–19 mmHg) 0.0332* 0.0016*
Group 2 (20–22 mmHg) 0.0332* 0.1067
Group 3 (23–25 mmHg) 0.0016* 0.1067
* statistically significant difference at p<0.05
M – mean reduction     
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SLT intervention. This suggests that 1 month is the mini-
mum amount of time between SLT and the assessment of 
procedure success.
Most studies have reported low complication rates, 
which correlates well with our findings. Transistent IOP 
elevation of treated eyes has been reported in other studies, 
usually within 2 hours after surgery and resolved within 
24 hours. Damji et al. [4] reported that 4.5% of treated 
eyes exhibited an IOP rise of 6 mmHg or greater within 1 
hour after treatment. Lai et al. [17] reported IOP spike of 5 
mmHg or higher in 10.3% of treated eyes. To our opinion, 
a careful selection power 0.1 mJ lower than cavitation bub-
bles formation power is very important for low complica-
tion rate, like IOP spikes and anterior chamber reaction, 
especially in heavily pigmented angles.
Reduction in the mean number of medications used in 
this group of patients rating from 2.83 to 2.68 is similar 
to other authors findings in patients with medically un-
controlled glaucoma [18], although we preferred for this 
group of patients’ target IOP to be as low as possible, thus 
we did not aim at reducing the number of eye drops.
CONCLUSION
SLT effectively lowers IOP in patients with medically un-
controlled primary open-angle glaucoma, and the inter-
vention was not accompanied by significant complications. 
Our results confirm the finding that a higher baseline IOP 
is the predictor of better IOP response after SLT [19]. We 
also found that first conclusive results were visible 1 month 
after the procedure. Our results also confirm that there 
were no significant side effects of selective laser trabecu-
loplasty [20].
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КРАТАК САДРЖАЈ
Увод Гла  у  ком је хро  нич  на, про  гре  сив  на бо  лест оч  ног жив  ца 
ко  ја, уко  ли  ко се не ле  чи, до  во  ди до не  по  врат  ног гу  бит  ка 
ви  да. До  ка  за  но је да сни  жа  ва  ње ин  тра  о  ку  лар  ног при  ти  ска 
(ИОП) успо  ра  ва на  пре  до  ва  ње бо  ле  сти. Сни  жа  ва  ње ИОП се 
по  сти  же ме  ди  ка  мент  ном, ла  сер  ском или хи  рур  шком те  ра-
пи  јом.
Циљ ра  да Циљ ра  да је био да се утвр  ди од  го  вор бо  ле  сни  ка 
с ме  ди  ка  мент  но не  кон  тро  ли  са  ним при  мар  ним гла  у  ко  мом 
отво  ре  ног угла на при  ме  ну се  лек  тив  не ла  сер  ске тра  бе  ку-
ло  пла  сти  ке (СЛТ).
Ме  то  де ра  да У сту  ди  ју је укљу  че  но 35 бо  ле  сни  ка (48 очи  ју) 
код ко  јих и уз при  ме  ну пу  не ме  ди  ка  мент  не те  ра  пи  је ни  су 
по  стиг  ну  те циљ  не вред  но  сти ИОП. Бо  ле  сни  ци ко  ји су под 
ова  квом те  ра  пи  јом има  ли при  ти  сак ве  ћи од 25 mm Hg ни  су 
би  ли укљу  че  ни у ис  тра  жи  ва  ње, већ су упу  ће  ни на хи  рур  шко 
ле  че  ње. ИОП је ме  рен на при  је  му, те је  дан сат, се  дам да  на, 
ме  сец да  на, три, шест и два  на  ест ме  се  ци по  сле СЛТ. Као за-
до  во  ља  ва  ју  ћи ефе  кат узи  ма  но је сни  же  ње ИОП од нај  ма  ње 
20% од по  чет  не вред  но  сти. Та  ко  ђе је ис  пи  тан ути  цај по  чет  не 
вред  но  сти ИОП на ње  го  ву вред  ност на кра  ју пе  ри  о  да кли-
нич  ког пра  ће  ња.
Ре  зул  та  ти Ис  пи  та  ни  ци су у про  се  ку има  ли 73±12 го  ди-
на. Сред  ња вред  ност по  чет  ног ИОП би  ла је 20,48 mm Hg 
(SD=1,91), док је про  сеч  но сма  ње  ње ИОП по  сле при  ме  не 
СЛТ би  ло 4,47 mm Hg (SD=2,12). Код очи  ју с ви  шим по  чет-
ним вред  но  сти  ма ИОП пад при  ти  ска на кра  ју ис  пи  ти  ва  ња 
био је ста  ти  стич  ки зна  чај  но ве  ћи. За  до  во  ља  ва  ју  ћи ефе  кат 
сни  же  ња ИОП по  сле го  ди  ну да  на по  стиг  нут је код 64,58% 
очи  ју. Сни  же  ње ИОП ни  је за  ви  си  ло од по  ла и ста  ро  сти ис-
пи  та  ни  ка.
За  кљу  чак СЛТ ефи  ка  сно сни  жа  ва ИОП код бо  ле  сни  ка с 
при  мар  ним гла  у  ко  мом отво  ре  ног угла, а ин  тер  вен  ци  ја ни-
је пра  ће  на зна  чај  ним ком  пли  ка  ци  ја  ма. Ре  зул  та  ти ис  тра  жи-
ва  ња по  твр  ђу  ју да је сни  же  ње ИОП зна  чај  ни  је уко  ли  ко је 
по  чет  на вред  ност ве  ћа. Пр  ви по  у  зда  ни ре  зул  та  ти сни  же  ња 
ИОП утвр  ђе  ни су ме  сец да  на од ин  тер  вен  ци  је, та  ко да ју не 
би тре  ба  ло по  на  вља  ти пре ис  те  ка пр  вог ме  се  ца.
Кључ  не ре  чи: ла  сер; при  мар  ни гла  у  ком отво  ре  ног угла; се-
лек  тив  на ла  сер  ска тра  бе  ку  ло  пла  сти  ка; ле  че  ње
Хипотензивни ефекат селективне ласерске трабекулопластике код болесника 
с медикаментно нерегулисаним примарним глаукомом отвореног угла
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